2m 2m 2m 2m 2m 2m 2m
Cytokinetics (CYTK)
NASDAQ
$82.40+$0.16 (+0.19%)
Price as of Jul 14, 2026 5:52 AM EDT- $11.2BMarket Cap
- 113.17%1-Year Change
- BiotechnologyIndustry
Cytokinetics (CYTK)
$82.40+$0.16 (+0.19%)
CYTK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $82.24 | ||
Change | -$2.63 (-3.10%) | ||
Open | $83.39 | ||
High | $84.60 | ||
Low | $80.90 | ||
Previous Close | $84.87 | ||
Volume | 1,891,495 | ||
30-Day Average Volume | 2,671,399 | ||
1-Week Change | -3.89% | ||
1-Month Change | 17.23% | ||
1-Year Change | 113.17% | ||
3-Year Change | 131.66% | ||
5-Year Change | 337.68% | ||
Fundamentals | |||
Shares Outstanding | 135.8M | ||
Total Assets | $1.3B | ||
Market Cap | $11.2B | ||
Enterprise Value | $11.3B | ||
Period: QTR TTM FY | |||
Revenue | $4.8M | ||
Net Income | -$206.0M | ||
Free Cash Flow | -$151.4M | ||
EBIT | -$191.5M | ||
EBITDA | -$188.1M | ||
Net Working Capital | $640.3M | ||
EPS | -$1.67 | ||
Enterprise Value/EBITDA | -60 | ||
Enterprise Value/Revenue | 2,365 | ||
P/B | -14 | ||
P/E | -49 | ||
PEG | -0 | ||
Price/Free Cash Flow | -74 | ||
Price/Operating Cash Flow | -77 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 6 | ||
Last Split Date | 06/25/2013 | ||
Earnings & Revenue